|Age:||18 years or older|
|Keywords:||Epstein Barr Virus, EBV, Nasopharyngeal Carcinoma, head and neck cancer|
|Type:||Drug study, Phase 2/3|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.
= Grade 2 peripheral sensory neuropathy (CTCAE, v. 4.0)
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.